The firm recorded Q4 oncology revenues of $4.06 billion compared to $3.19 billion in the same period last year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback